Form 4: Saul Centers Director John Chapoton Reports Acquisition of Phantom Stock
SEC Form 4
Director John Chapoton reports acquisition of phantom stock in Saul Centers, Inc. through a deferred compensation plan.
Summary
- On January 2, 2025, Director John E. Chapoton reported changes in beneficial ownership of Saul Centers, Inc. securities.
- The report details the acquisition of 418.814 phantom shares under the Issuer's Deferred Compensation Plan for Directors.
- These phantom shares are convertible into common stock according to the terms of the Deferred Compensation Plan and the reporting person's Deferred Fee Agreement.
- Chapoton also holds multiple director stock options with various exercise prices and expiration dates, each for 2,500 shares of common stock.
- Following the reported transaction, Chapoton beneficially owns 9,466.078 shares of common stock directly and 26,052.855 phantom shares.
- The report also includes 388.019 shares awarded October 31, 2024 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which doesn't inherently suggest positive or negative implications.
Positives
- The acquisition of phantom stock suggests continued alignment of the director's interests with those of the shareholders.
- The director's continued holding of stock options indicates a long-term commitment to the company's success.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of phantom stock could be viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date exercisable for Director Stock Option with an exercise price of $51.07, expiring on 05/08/2025 |
| 05/06/2016 | Date exercisable for Director Stock Option with an exercise price of $57.74, expiring on 05/06/2026 |
| 05/05/2017 | Date exercisable for Director Stock Option with an exercise price of $59.41, expiring on 05/05/2027 |
| 05/11/2018 | Date exercisable for Director Stock Option with an exercise price of $49.46, expiring on 05/11/2028 |
| 05/03/2019 | Date exercisable for Director Stock Option with an exercise price of $55.71, expiring on 05/03/2029 |
| 04/24/2020 | Date exercisable for Director Stock Option with an exercise price of $50, expiring on 04/24/2030 |
| 05/07/2021 | Date exercisable for Director Stock Option with an exercise price of $43.89, expiring on 05/07/2031 |
| 05/13/2022 | Date exercisable for Director Stock Option with an exercise price of $47.9, expiring on 05/13/2032 |
| 05/12/2023 | Date exercisable for Director Stock Option with an exercise price of $33.79, expiring on 05/12/2033 |
| 05/17/2024 | Effective date of the amended and restated Deferred Compensation Plan for Directors. |
| 10/31/2024 | Date of dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan. |
| 01/02/2025 | Date of the reported transaction: acquisition of phantom shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.